Richard Pulik
Director of Finance/CFO at ROIVANT SCIENCES LTD.
Net worth: 3 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Venker | M | 37 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 years |
| Matthew Gline | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
| Ilan Oren | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 years |
| Keith Manchester | M | 55 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 years |
| Clarence Machado | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 7 years |
| Mayukh Sukhatme | M | 48 | 9 years | |
| Melissa Epperly | F | 46 | 2 years | |
| Rakhi Kumar | F | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 years |
| Meghan Fitzgerald | M | 53 | 1 years | |
| Jim Momtazee | M | - | 3 years | |
| Howard Marks | M | 77 |
University of Pennsylvania
| 24 years |
| Dan Gold | M | 56 | 4 years | |
| Sakshi Chhabra | F | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
| Leah Popowich | F | 45 |
University of Pennsylvania
| 24 years |
| Raphael Amit | M | 77 |
University of Pennsylvania
| 25 years |
| Nikhil Kehtarpal | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| Navneet Alag | M | - | 2 years | |
| Mukul Mehta | M | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 5 years |
| Jo Chen | M | - | 4 years | |
| Paul Davis | M | - | 8 years | |
| Zachary Carpenter | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| Kelly Graff | F | - | 4 years | |
| Drew Kramer | M | - | - | |
| Amy Mahery | F | 47 | 2 years | |
| Srini Ramanathan | M | - | 2 years | |
| Terrie Curran | F | 55 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Paul Davis | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
| Kathleen Sebelius | F | 75 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Sef P. Kurstjens | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Wan Li Zhu | M | - | 3 years | |
| Frank Torti | M | 45 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
| Atul Pande | M | 69 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Pierre Legault | M | 63 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Berndt A. E. Modig | M | 65 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Kenneth Ludlum | M | 70 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Timothy Nelson | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Mark Guinan | M | 62 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Andrew Fromkin | M | 58 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
| George Bickerstaff | M | 68 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Stephanie Griffin | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vivek Ramaswamy | M | 38 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 years |
| Salvatore Tirabassi | M | - |
University of Pennsylvania
| 3 years |
| Sassan Alizadeh | M | - |
University of Pennsylvania
| 7 years |
| Peter M. Lamb | M | - |
University of Pennsylvania
| 3 years |
| Nehal Kamalapat Chopra | F | - |
University of Pennsylvania
| 4 years |
| Charles Hebard | M | - |
University of Pennsylvania
| 11 years |
| Tae Yamaura | F | - |
University of Pennsylvania
| 2 years |
| Bill Belleville | M | - |
University of Pennsylvania
| 2 years |
| Elizabeth Diffley | F | - |
University of Pennsylvania
| 8 years |
| Simón Gaviria Muñoz | M | 43 |
University of Pennsylvania
| 4 years |
| David A. Cohen | M | - |
University of Pennsylvania
| 13 years |
| Vijay Chattha | M | - |
University of Pennsylvania
| 5 years |
| Sean Evan Wright | M | 50 |
University of Pennsylvania
| 2 years |
| Robert Doebele | M | 53 |
University of Pennsylvania
| 4 years |
| Eric Zoller | M | - |
University of Pennsylvania
| 7 years |
| Maja Sliwinski | F | - |
University of Pennsylvania
| 6 years |
| Thomas Pologruto | M | - |
University of Pennsylvania
| 4 years |
| Peter Atadja | M | 64 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 24 years |
| Andrew Lo | M | 63 | 6 years | |
| César Orosco | M | - |
University of Pennsylvania
| 6 years |
| Nachi Gupta | M | - |
University of Pennsylvania
| 3 years |
| Taran Sang Yong Bae | M | - |
University of Pennsylvania
| 2 years |
| Mehul Trivedi | M | 53 |
University of Pennsylvania
| 9 years |
| David M. Hollond | M | - |
University of Pennsylvania
| 2 years |
| Chuck Myers | M | - |
University of Pennsylvania
| 5 years |
| Vijai P. Mohan | M | - |
University of Pennsylvania
| 5 years |
| Doug Asiello | M | 54 |
University of Pennsylvania
| 3 years |
| James S. Riepe | M | - |
University of Pennsylvania
| 4 years |
| Saam Farhang | M | - |
University of Pennsylvania
| 5 years |
| Robert J. Fioretti | M | - |
University of Pennsylvania
| 12 years |
| Wen Kai Xiang | M | - |
University of Pennsylvania
| 4 years |
| Sérgio Ricardo Miranda Nazaré | M | 61 |
University of Pennsylvania
| 1 years |
| Thuy Tran | M | - |
University of Pennsylvania
| 2 years |
| Yvette Pasqua | F | - |
University of Pennsylvania
| 4 years |
| Richard Rothfeld | M | - |
University of Pennsylvania
| 4 years |
| Stefan Sterns | M | - |
University of Pennsylvania
| 4 years |
| Alyse D Bodine | F | - |
University of Pennsylvania
| 4 years |
| David Berdon | M | - |
University of Pennsylvania
| 2 years |
| Alex Abrams | M | - |
University of Pennsylvania
| 4 years |
| CHALAL ISAAC S | M | - |
University of Pennsylvania
| 4 years |
| Matthew M. McDonald | M | 57 |
University of Pennsylvania
| 3 years |
| David Beznos | M | - |
University of Pennsylvania
| 4 years |
| Matthew S. Levine | M | 49 |
University of Pennsylvania
| 4 years |
| Joseph Galone | M | - |
University of Pennsylvania
| 4 years |
| Hiroshi Nomura | M | 66 | 1 years | |
| Joseph McKnight | M | - |
University of Pennsylvania
| 4 years |
| Arun Rao | M | - |
University of Pennsylvania
| 4 years |
| Zal Bilimoria | M | - |
University of Pennsylvania
| 4 years |
| Joshua Beer | M | - |
University of Pennsylvania
| 4 years |
| Jeffrey P. Gerson | M | - |
University of Pennsylvania
| 4 years |
| Wendell Pritchett | M | 59 |
University of Pennsylvania
| 3 years |
| Douglas Winston Kennedy | M | - |
University of Pennsylvania
| 4 years |
| Matthew Wilson | M | - |
University of Pennsylvania
| 2 years |
| Benjamin Levy | M | - |
University of Pennsylvania
| 4 years |
| Atul Tantia | M | 59 |
University of Pennsylvania
| 4 years |
| Sabir J. Rassiwalla | M | - |
University of Pennsylvania
| 4 years |
| Kiel Berry | M | - |
University of Pennsylvania
| 4 years |
| Slava Rubin | M | 45 |
University of Pennsylvania
| 4 years |
| Ed Zane | M | - |
University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 84 | 84.00% |
| United Kingdom | 23 | 23.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Pulik
- Personal Network
